MorphoSys AG buy elbawind
Summary
This prediction ended on 04.09.09 with a price of €14.96. With a performance of 6.86%, the BUY prediction by elbawind for MorphoSys AG closed with a slight gain. elbawind has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 5.306% | 5.306% | 218.490% | 2.907% |
| iShares Core DAX® | -0.051% | 4.829% | 17.062% | 18.811% |
| iShares Nasdaq 100 | 1.659% | 2.417% | 38.705% | 56.555% |
| iShares Nikkei 225® | 0.658% | -2.173% | 13.159% | 7.768% |
| iShares S&P 500 | 0.964% | 2.547% | 30.492% | 47.355% |
Comments by elbawind for this prediction
In the thread Morphosys AG diskutieren
Zwischenspurt
Morphosys läuft seit Aug.07 in einem Aufwärtstrendkanal, aus dem der Kurs am 6.3.09 nach unten ausgebrochen ist. Z.Zt. versucht der Kurs bei 14€ wieder in den Kanal einzutreten. Wenn dies geschehen ist, steigt der Kurs von Morphosys gewöhnlich sehr schnell an die obere Grenze des Kanals, die ca. 26% von der unteren entfernt liegt. Anfang Juli müßte ein Kurs von 18€ erreicht sein.